No Data
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024
With 60% Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Boasts of Strong Institutional Backing
Vir Biotechnology Names Jason O'Byrne Finance Chief
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
Caribou Biosciences Announces CFO Resignation and Succession Plan